Technology

Anchiano Therapeutics

$2.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-3.13%) Today
-$0.06 (-2.42%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ANCN and other stocks, options, and ETFs commission-free!

About ANCN

Anchiano Therapeutics Ltd. American Depositary Share, also called Anchiano Therapeutics, is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. The listed name for ANCN is Anchiano Therapeutics Ltd. American Depositary Share.

CEO
Neil Cohen
Employees
16
Headquarters
Jerusalem, Jerusalem
Founded
2004
Market Cap
17.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
323.64K
High Today
$2.75
Low Today
$2.45
Open Price
$2.59
Volume
443.39K
52 Week High
$5.49
52 Week Low
$0.5136

Collections

ANCN Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 17

You May Also Like

ADS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure